Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
7.58
+0.15 (2.02%)
At close: Aug 21, 2026, 4:00 PM EDT
7.74
+0.16 (2.11%)
After-hours: Aug 21, 2026, 7:30 PM EDT

Instil Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-36.95-52.91-59.96-90.54-206.17-155.27
Net Income
-30.28-71.37-74.14-156.09-223.18-156.79
Earnings Per Share
-4.47-10.70-11.39-24.00-34.46-29.59
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
69.6876.13113.32151.41263.12454.1
Total Debt
87.0385.1886.8986.0579.9-
Net Cash (Debt)
-17.35-9.0526.4365.36183.22454.1
Net Cash Growth
---59.56%-64.33%-59.65%87.87%
Net Cash Per Share
-2.56-1.364.0610.0528.2985.68

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-23.61-36.62-55.7-82.03-180.16-122.14
Capital Expenditures
----20.66-84.59-57.83
Free Cash Flow
-23.61-36.62-55.7-102.69-264.75-179.97
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation

Selected indicators aren't available for this stock.